Legend Biotech Corp - ADR

Legend Biotech Corp - ADR

LEGN

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.43B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Legend Biotech Corp - ADRLegend Biotech Corp - ADR-13.6--26%3.20.4
$53.78

Target Price by Analysts

181.1% upsideLegend Biotech Target Price DetailsTarget Price

Share Statistics

Market cap$3.43 Billion
Enterprise Value$3.18 Billion
Dividend Yield$- (-)
Earnings per Share$-1.6
Beta0.34
Outstanding Shares184,733,092

Return

Return on Equity-25.94%ROE
Return on Assets-15.72%
Return on Invested Capital-20.25%

Valuation & Multiples

P/E Ratio-13.64P/E Ratio
PEG29.63PEG
Price to Sales3.19Price to Sales
Price to Book Ratio3.83Price to Book Ratio
Enterprise Value to Revenue2.78
Enterprise Value to EBIT-14.44
Enterprise Value to Net Income-13
Total Debt to Enterprise0.12
Debt to Equity0.41Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 19, 2026
EPS Estimate
$0.03
Average shareholder expectation
Revenue Estimate
$321.82 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 10, 2026
EPS Estimate
$0.06
Average shareholder expectation
Revenue Estimate
$356.01 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 72.21%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.20% 49.46%
Total Invested$117.33M 93.20%
Investors Holding44 163.00%

ESG Score

No data

About Legend Biotech Corp